Amiodarone liver toxicity about two cases and review of literature;Hépatotoxicité de l'amiodarone à propos de deux observations et revue de la littérature

Revue de Medecine Interne

Volumn 25, Issue 5, 2004, Pages 386-389

  Iba ba, J ^a   Tilea, M ^b   Balligand, J L ^b   Lefebvre, C ^b  

^a Cliniques Universitaires Saint Luc ^*  (Gabon)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Amiodarone; Hepatitis; H patite; Phospholipidose; Phospholipidosis; Steatosis; St atose

Indexed keywords

AMIODARONE;

CASE REPORT; DRUG SAFETY; FATALITY; HISTOLOGY; HUMAN; LIPIDOSIS; LIVER DYSFUNCTION; LIVER TOXICITY; PATIENT MONITORING; REVIEW; STEATOSIS; TREATMENT OUTCOME;

EID: 2142827067     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.02.005     Document Type: Article

References (22)

1. Masson J.W. Amiodarone. N Engl J Med. 316:1987;455-466
2. Berson A., De Beco V., Letteron P., Robin M.A., Moreau C., El Kahwaji J., et al. Steatohepatitis-inducing drugs caused mitochondrial dysfonction and lipid peroxdation in rat hepatocytes. Gastroenterology. 114:1998;764-774
3. Groh W.C., Kastor J.A., Josephson M.E., Horowitz L.N. Amiodarone: an effective drug for refractory ventricular tachycardia. Circulation. 62:1980;151-152
4. Morse R.M., Valenzuela G.A., Greenwald T.P., Eulie P.J., Wesley R.C., Mc Callum R.W. Amiodarone induced liver toxicity. Ann Intern Med. 109:1988;834-840
5. Fogoros R.N., Anderson K.P., Winkle R.A., Swerdlow C.D., Mason J.W. Amiodarone: clinical efficacy and toxicyty in 96 patients with recurrent, drug- refractory arrhythmias. Circulation. 68:1983;88-94
6. Rigas B. The evolving spectrum of amiodarone hepatotoxicity. Hepatology. 10:1989;116-117
7. De Korwin J.D., Gagey S., Paille F., Zannad F., Schmitt J. Hépatite aiguë imputée à l'amiodarone. Gastroenterol Clin Biol. 10:1986;688-689
8. Rotmensch H.H., Belhassen B., Swanson B.N., Shoshani D., Spielman S.R., Greenspon A.J. Steady state serum amiodarone concentrations: relationships with antiarythmic efficacity and toxycity. Ann intern Med. 101:1984;462-469. et coll.
9. Simon J.B., Manley P.N., Brien J.F., Armstrong P.W. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med. 311:1984;167-172
10. Capron-Chivrac D., Reix N., Quenum C., Capron J.P. Hépatopathie aigüe due à l'amiodarone. Gastroenterol Clin Biol. 9:1985;535-539
11. Gilinski N.H., Briscoe G.W., Kuo C.S. Fatal amiodarone hepatotoxicity. Am J Gastroenterol. 83:1988;161-163
12. Snir Y., Pick N., Riesenberg K., Yanai-inbar I., Zirkin H., Schlaeffer F. Fatal hepatic failure due to prolonged amiodarone treatment. J Clin Gastroenterol. 20:1995;265-266
13. Richer M., Robert S. Fatal hepatotoxicity following oral administration of amiodarone. Ann Pharmacother. 29:1995;582-586
14. Lim P.K., Trewby P.N., Storey G.C., Hole D.W. Neuropathy and fatal hepatitis in a patient receiving amiodarone. Br Med J. 288:1984;1638-1639
15. Lamproye A., Ramos J., Larrey D., Belaiche J. Hépatite pseudo-alcoolique et cirrhose induite par l'amiodarone. Rev Med Liège. 53:1998;121-124
16. Lewis J.H., Mullick F., Ishak K.G., Ranard R.C., Ragsdale B., Perse R.M., et al. Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol. 21:1990;59-67
17. Morgan M.Y., Reshef R., Shah R.R., Oates N.S., Smith R.L., Sherlock. Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut. 25:1984;1057-1064
18. e:2000;. réunion nationale
19. Pirovino M., Honegger U., Muller O., Zysset T., Kupfer A., Tinel M., et al. Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylater phenotype? Br J Pharmacol. 99:1990;35-40
20. Guigui B., Perrot S., Berry J.P., Fleury-Feith J., Martin N., Metreau J.M., et al. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver desease. Hepatology. 8:1998;1063-1068
21. Babany G., Dhumeaux D. Hepatotoxic amiodarone. Gastroenterol Clin Biol. 9:1985;505-507
22. Goldman I.S., Winkler M.L., Raper S.E., Barker M.E., Keung E., Goldberg H.I., et al. Increased hepatic density and phospholipidosis due to cordarone. Am J Roentgenol. 144:1985;541-546